What is the expected market size of the Japan Dysmenorrhea Treatment Market in 2024?

The Japan Dysmenorrhea Treatment Market is expected to be valued at 153.0 million USD in 2024. Read More

What is the projected market value of the Japan Dysmenorrhea Treatment Market by 2035?

By 2035, the market is projected to reach a value of 585.0 million USD. Read More

What is the expected CAGR for the Japan Dysmenorrhea Treatment Market from 2025 to 2035?

The market is expected to grow at a CAGR of 12.967 percent during the period from 2025 to 2035. Read More

Which product type holds a dominant market share within the Japan Dysmenorrhea Treatment Market?

Primary Dysmenorrhea is expected to dominate the market with a valuation of 90.0 million USD in 2024. Read More

What will be the market size for Primary Dysmenorrhea by 2035?

The market for Primary Dysmenorrhea is anticipated to grow to 345.0 million USD by 2035. Read More

How much is the Secondary Dysmenorrhea market valued at in 2024?

In 2024, the market for Secondary Dysmenorrhea is valued at 63.0 million USD. Read More

What is the projected market size for Secondary Dysmenorrhea by 2035?

The market for Secondary Dysmenorrhea is expected to reach about 240.0 million USD by 2035. Read More

What are the growth opportunities in the Japan Dysmenorrhea Treatment Market?

The market offers growth opportunities in terms of innovation in treatment options and increasing awareness among women. Read More

What are the challenges facing the Japan Dysmenorrhea Treatment Market?

Challenges include the need for effective marketing strategies and addressing potential side effects associated with treatments. Read More

Japan Dysmenorrhea Treatment Market

Q: Who are the key players in the Japan Dysmenorrhea Treatment Market?

Key players include Fujifilm Corporation, Takeda Pharmaceutical Company, Astellas Pharma, and Novartis, among others. Read More

ID: MRFR/MED/52777-HCR

200 Pages

Rahul Gotadki

Last Updated: July 15, 2026

Japan Dysmenorrhea Treatment Market Research Report: Size, Share, Trend Analysis By Product Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), By Types of Treatment (Pain Relievers, Hormonal Therapy, Surgery), andBy End-User (Hospitals & Clinics, Research Centers) - Growth Outlook & Industry Forecast 2025 To 2035

Japan Dysmenorrhea Treatment Market

Market Size

Forecast Period2025-2035

CAGR (2025-2035)12.97%

2018 Market Size$ 141.75 Million

2024 Market Size$ 153 Million

2035 Market Size$ 585 Million

Key Players

Fujifilm Corporation

Takeda Pharmaceutical Company

Astellas Pharma

Novartis

Sanofi

Eisai Co

Trends

Cultural Shifts Boost Demand for Holistic Care
Digital Health and Government Support Expand Opportunities

Opportunities

Digital Health Integration and Innovation in Women's Care
Growing Adoption of Personalized Women's Health Management

Summary Table of Contents Segmentation Download PDF

1 EXECUTIVE SUMMARY
1. 1.1 Market Overview
2. 1.2 Key Findings
3. 1.3 Market Segmentation
4. 1.4 Competitive Landscape
5. 1.5 Challenges and Opportunities
6. 1.6 Future Outlook
2 MARKET INTRODUCTION
1. 2.1 Definition
2. 2.2 Scope of the study
  1. 2.2.1 Research Objective
  2. 2.2.2 Assumption
  3. 2.2.3 Limitations
3 RESEARCH METHODOLOGY
1. 3.1 Overview
2. 3.2 Data Mining
3. 3.3 Secondary Research
4. 3.4 Primary Research
  1. 3.4.1 Primary Interviews and Information Gathering Process
  2. 3.4.2 Breakdown of Primary Respondents
5. 3.5 Forecasting Model
6. 3.6 Market Size Estimation
  1. 3.6.1 Bottom-Up Approach
  2. 3.6.2 Top-Down Approach
7. 3.7 Data Triangulation
8. 3.8 Validation
4 MARKET DYNAMICS
1. 4.1 Overview
2. 4.2 Drivers
3. 4.3 Restraints
4. 4.4 Opportunities
5 MARKET FACTOR ANALYSIS
1. 5.1 Value chain Analysis
2. 5.2 Porter's Five Forces Analysis
  1. 5.2.1 Bargaining Power of Suppliers
  2. 5.2.2 Bargaining Power of Buyers
  3. 5.2.3 Threat of New Entrants
  4. 5.2.4 Threat of Substitutes
  5. 5.2.5 Intensity of Rivalry
3. 5.3 COVID-19 Impact Analysis
  1. 5.3.1 Market Impact Analysis
  2. 5.3.2 Regional Impact
  3. 5.3.3 Opportunity and Threat Analysis
6 Japan Dysmenorrhea Treatment Market, BY PRODUCT TYPE (USD MILLION)
1. 6.1 Primary Dysmenorrhea
2. 6.2 Secondary Dysmenorrhea
7 Japan Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT (USD MILLION)
1. 7.1 Pain Relievers
2. 7.2 Hormonal Therapy
3. 7.3 Surgery
8 Japan Dysmenorrhea Treatment Market, BY END-USER (USD MILLION)
1. 8.1 Hospitals & Clinics
2. 8.2 Research Centers
9 COMPETITIVE LANDSCAPE
1. 9.1 Overview
2. 9.2 Competitive Analysis
3. 9.3 Market share Analysis
4. 9.4 Major Growth Strategy in the Dysmenorrhea Treatment Market
5. 9.5 Competitive Benchmarking
6. 9.6 Leading Players in Terms of Number of Developments in the Dysmenorrhea Treatment Market
7. 9.7 Key developments and growth strategies
  1. 9.7.1 New Product Launch/Service Deployment
  2. 9.7.2 Merger & Acquisitions
  3. 9.7.3 Joint Ventures
8. 9.8 Major Players Financial Matrix
  1. 9.8.1 Sales and Operating Income
  2. 9.8.2 Major Players R&D Expenditure. 2023
10 COMPANY PROFILES
1. 10.1 Fujifilm Corporation
  1. 10.1.1 Financial Overview
  2. 10.1.2 Products Offered
  3. 10.1.3 Key Developments
  4. 10.1.4 SWOT Analysis
  5. 10.1.5 Key Strategies
2. 10.2 Takeda Pharmaceutical Company
  1. 10.2.1 Financial Overview
  2. 10.2.2 Products Offered
  3. 10.2.3 Key Developments
  4. 10.2.4 SWOT Analysis
  5. 10.2.5 Key Strategies
3. 10.3 Astellas Pharma
  1. 10.3.1 Financial Overview
  2. 10.3.2 Products Offered
  3. 10.3.3 Key Developments
  4. 10.3.4 SWOT Analysis
  5. 10.3.5 Key Strategies
4. 10.4 Novartis
  1. 10.4.1 Financial Overview
  2. 10.4.2 Products Offered
  3. 10.4.3 Key Developments
  4. 10.4.4 SWOT Analysis
  5. 10.4.5 Key Strategies
5. 10.5 Sanofi
  1. 10.5.1 Financial Overview
  2. 10.5.2 Products Offered
  3. 10.5.3 Key Developments
  4. 10.5.4 SWOT Analysis
  5. 10.5.5 Key Strategies
6. 10.6 Eisai Co
  1. 10.6.1 Financial Overview
  2. 10.6.2 Products Offered
  3. 10.6.3 Key Developments
  4. 10.6.4 SWOT Analysis
  5. 10.6.5 Key Strategies
7. 10.7 Johnson & Johnson
  1. 10.7.1 Financial Overview
  2. 10.7.2 Products Offered
  3. 10.7.3 Key Developments
  4. 10.7.4 SWOT Analysis
  5. 10.7.5 Key Strategies
8. 10.8 Pfizer
  1. 10.8.1 Financial Overview
  2. 10.8.2 Products Offered
  3. 10.8.3 Key Developments
  4. 10.8.4 SWOT Analysis
  5. 10.8.5 Key Strategies
9. 10.9 Merck & Co
  1. 10.9.1 Financial Overview
  2. 10.9.2 Products Offered
  3. 10.9.3 Key Developments
  4. 10.9.4 SWOT Analysis
  5. 10.9.5 Key Strategies
10. 10.10 AbbVie
  1. 10.10.1 Financial Overview
  2. 10.10.2 Products Offered
  3. 10.10.3 Key Developments
  4. 10.10.4 SWOT Analysis
  5. 10.10.5 Key Strategies
11. 10.11 Teva Pharmaceutical Industries
  1. 10.11.1 Financial Overview
  2. 10.11.2 Products Offered
  3. 10.11.3 Key Developments
  4. 10.11.4 SWOT Analysis
  5. 10.11.5 Key Strategies
12. 10.12 Bayer
  1. 10.12.1 Financial Overview
  2. 10.12.2 Products Offered
  3. 10.12.3 Key Developments
  4. 10.12.4 SWOT Analysis
  5. 10.12.5 Key Strategies
13. 10.13 GlaxoSmithKline
  1. 10.13.1 Financial Overview
  2. 10.13.2 Products Offered
  3. 10.13.3 Key Developments
  4. 10.13.4 SWOT Analysis
  5. 10.13.5 Key Strategies
14. 10.14 Hikma Pharmaceuticals
  1. 10.14.1 Financial Overview
  2. 10.14.2 Products Offered
  3. 10.14.3 Key Developments
  4. 10.14.4 SWOT Analysis
  5. 10.14.5 Key Strategies
15. 10.15 Mylan N.V.
  1. 10.15.1 Financial Overview
  2. 10.15.2 Products Offered
  3. 10.15.3 Key Developments
  4. 10.15.4 SWOT Analysis
  5. 10.15.5 Key Strategies
11 APPENDIX
1. 11.1 References
2. 11.2 Related Reports
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 JAPAN DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES & Japan Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 3 JAPAN DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES & Japan Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019-2035 (USD BILLIONS)
TABLE 4 JAPAN DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES & Japan Dysmenorrhea Treatment Market, BY END-USER, 2019-2035 (USD BILLIONS)
TABLE 5 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 6 ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN DYSMENORRHEA TREATMENT MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 3 JAPAN DYSMENORRHEA TREATMENT MARKET ANALYSIS BY TYPE OF TREATMENT
FIGURE 4 JAPAN DYSMENORRHEA TREATMENT MARKET ANALYSIS BY END-USER
FIGURE 5 KEY BUYING CRITERIA OF DYSMENORRHEA TREATMENT MARKET
FIGURE 6 RESEARCH PROCESS OF MRFR
FIGURE 7 DRO ANALYSIS OF DYSMENORRHEA TREATMENT MARKET
FIGURE 8 DRIVERS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT MARKET
FIGURE 9 RESTRAINTS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT MARKET
FIGURE 10 SUPPLY / VALUE CHAIN: DYSMENORRHEA TREATMENT MARKET
FIGURE 11 Japan Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2025 (% SHARE)
FIGURE 12 Japan Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
FIGURE 13 Japan Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2025 (% SHARE)
FIGURE 14 Japan Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019 TO 2035 (USD Billions)
FIGURE 15 Japan Dysmenorrhea Treatment Market, BY END-USER, 2025 (% SHARE)
FIGURE 16 Japan Dysmenorrhea Treatment Market, BY END-USER, 2019 TO 2035 (USD Billions)
FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS

Certified Researchers

Customize Report

Japan Dysmenorrhea Treatment Market Segmentation

Japan Dysmenorrhea Treatment Market By Product Type (USD Million, 2019-2035)
- Primary Dysmenorrhea
- Secondary Dysmenorrhea

Japan Dysmenorrhea Treatment Market By Type of Treatment (USD Million, 2019-2035)
- Pain Relievers
- Hormonal Therapy
- Surgery

Japan Dysmenorrhea Treatment Market By End-User (USD Million, 2019-2035)
- Hospitals & Clinics
- Research Centers

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”